Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2001, p. 3409-3415, Vol. 45, No. 12
INSERM U511, Immunobiologie Cellulaire
et Moléculaire des Infections Parasitaires, CHU
Pitié-Salpêtrière, 75643 Paris Cedex
13,1 and Centre National de la Recherche
Scientifique, Station Biologique, 29682 Roscoff
Cedex,3 France, and Cancer Research
Institute, Arizona State University, Tempe, Arizona
85287-16042
Received 9 April 2001/Returned for modification 4 June
2001/Accepted 31 August 2001
The antiparasitic effect of a collection of compounds with
antimitotic activity has been tested on a mammalian cell line infected with Encephalitozoon intestinalis, a microsporidian
causing intestinal and systemic infection in immunocompromised
patients. The antiparasitic effect was evaluated by counting the number
of parasitophorous vacuoles detected by immunofluorescence. Out of 526 compounds tested, 2 (pancratistatin and 7-deoxynarciclasine) inhibited
the infection without affecting the host cell. The 50% inhibitory concentrations (IC50s) of pancratistatin and
7-deoxynarciclasine for E. intestinalis were 0.18 µM
and 0.2 µM, respectively, approximately eightfold lower than the
IC50s of these same compounds against the host cells.
Electron microscopy confirmed the gradual decrease in the number of
parasitophorous vacuoles and showed that of the two life cycle phases,
sporogony was more sensitive to the inhibitors than merogony.
Furthermore, the persistence of meronts in some cells apparently
devoid of sporonts and spores indicated that the inhibitors block
development rather than entry of the parasite into the host cell. The
occurrence of binucleate sporoblasts and spores suggests that these
inhibitors blocked a specific phase of cell division.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3409-3415.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro Activities of Two Antimitotic Compounds,
Pancratistatin and 7-Deoxynarciclasine, against
Encephalitozoon intestinalis, a Microsporidium
Causing Infections in Humans
*
Corresponding author. Mailing address: INSERM Unit 511, CHU Pitié-Salpêtrière, 91 Bd de l'hôpital,
75643 Paris Cedex 13, France. Phone: (33) 1 40 77 81 05. Fax: (33) 1 45 83 88 58. E-mail: desporte{at}ext.jussieu.fr.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»